US Patent Issued to Amygdala Neurosciences on July 8 for "ALDH-2 inhibitor compounds and methods of use" (California Inventor)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,569, issued on July 8, was assigned to Amygdala Neurosciences Inc. (San Francisco).

"ALDH-2 inhibitor compounds and methods of use" was invented by Brent Blackburn (Los Altos, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are aldehyde dehydrogenase (ALDH-2) inhibitor compounds, such as a compounds of Formula (I) or Formula (II), pharmaceutical compositions comprising these inhibitor compounds, and uses of these compounds and compositions, such as in the methods for safely treating chemical dependency on a substance or condition of addiction, such as alcohol, nicotine, cocaine, opiates, amphetamines, and compulsive eating diso...